Combining hyperthermia and ionising radiation:





Combining hyperthermia and Ionising Radiation: 





A thesis submitted in the fulfilment of the requirements for the Degree of 
 
Master of Science in Medical Physics 
 





Latoya C. A. Flewellen 
 
University of Canterbury, 











Basic in vitro cell experiments were conducted on the P388 mouse leukaemia cell line 
to determine whether a supra-additive cell killing effect from combining hyperthermia 
with ionising radiation exists in the case of leukaemia. Methods were established to 
measure the cell kill, using a Coulter counter, from hyperthermia alone, radiation 
alone and several combined regimes. The cell kill from hyperthermia, in the range of 
38-50 degrees for 30 minutes, 1 hour, 2 hours and 3 hours, and radiation, for 1, 3, 5, 9, 
11 and 15 Gy was investigated. The approach used had various limitations, such as 
the underestimation of cell kill. Consistent trends, however, were found for the 
hyperthermia and radiation data, in accordance with the literature, which killed cells 
in a predictable manner. Subsequently, after other preliminary combined experiments 
were completed, the cell kill from both 5 and 11 Gy combined with hyperthermia at 
43, 45 and 47 degrees for 2 hours were investigated. 5 Gy in combination with all 
levels of hyperthermia resulted in a direct additive cell killing effect. This, however, 
was not observed for 11 Gy in which a diminished effect was found. The overall level 
of cell kill from 5 Gy combined with hyperthermia was found to be equal, in the case 
of 43 degrees, or higher, as for 45 and 47 degrees, to that of those combined with 11 
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1.1  INTRODUCTION 
 
Leukaemia is a cancer of the blood that, especially in the case of acute 
leukaemia, requires a bone marrow transplant (BMT) to fully cure the disease 1-3. The 
‘gold standard’ conditioning regime used to prepare leukaemia patients for a BMT 
consists of a course of chemotherapy followed by fractionated total body irradiation 
(TBI) 4-8. The chemotherapeutic agent, usually cyclophosphamide, is 
immunosuppressive and administered daily for approximately seven days. This 
ensures that there is no immune response when the patient receives the donor marrow 
1,3
. Following chemotherapy, the patient is subjected to a fractionated course of TBI 
where the total dose received by the patient can range from ten to fifteen gray (Gy), 
depending on the patient and the institution at which it is provided 4. These doses are 
delivered either by cobalt-60 treatment units or by using photon beams of 4-6 MV 
maximal energy from linear accelerators 9. TBI is administered primarily to kill the 
leukaemic cells throughout the body and consequently to create new spaces in the 
bone marrow that the new graft will fill 1,3. Fractionation allows for a higher 
biologically effective dose that results in fewer relapses and thus a longer overall 
survival 10.  
 Since TBI targets the bone marrow, many organs lie within the constructed 
radiation fields and receive high radiation doses. Improvements in the delivery of 
TBI, such as the design of a translational or moving treatment couch as by Papiez et 
al. 11 and Sarfaraz et al. 12, are aimed at developing a more homogenous dose 
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distribution in the patient. The side effects from TBI that can present in a patient are 
very distinct from those by chemotherapy and are well documented in the literature 
4,13
. Partial lung-shielding blocks are common practice at most institutions and serve 
to reduce the total lung dose. This, consequently, reduces the risk of patients 
developing interstitial pneumonia, a common side effect from which patients tend to 
succumb 14. Recently, Nakagawa et al. published two different papers that separately 
describe the shielding of the kidneys 15 and the ovaries 16. Renal shielding has become 
standardised at their institution, where the overall dose to the kidneys has been 
reduced from 12 to 10 Gy. All patients undergoing standard TBI procedures become 
sterile and thus Nakagawa et al. studied the effects of ovarian shielding in three 
women in whom they reduced the total dose to the ovaries from 12 to 3.125 Gy. Two 
out of three women seemingly retained their normal ovarian function and it was 
indicated that a longer follow up is required to determine whether both can 
successfully reproduce 16.  
Other side effects from TBI include the development of cataracts, endocrine 
dysfunction and long-term developmental effects in children 9,14,17. It quickly becomes 
obvious that there is a distinct need to improve the ‘gold standard’ conditioning 
regime that is currently in place. An alternative regime that combines TBI and an 
adjunct therapy to reduce the overall TBI dose would be ideal. Such an adjunct 
therapy must in itself have minimal side effects and allow for the same therapeutic 
efficacy as TBI alone currently provides. 
Mild hyperthermia as a therapy is known to satisfy the first of these 
requirements as whole-body hyperthermia (WBH) up to 41.8ºC generally has no 
significant side effects if its applied using the ‘radiant heat device’ as described by 
Robins et al. 18. It is yet to be determined whether the same therapeutic efficacy can 




 Hyperthermia has been recognised to be effective in the treatment of various 
types of cancer for over a century 19,20. Scientific research using this modality peaked 
in the 1960s and 1970s. During these time periods, the cell-killing properties of 
hyperthermia were investigated. Multiple studies have shown that cells most sensitive 
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to hyperthermia are either hypoxic or in the late S-phase of the cell-cycle 21-26. This 
greatly contrasts cell sensitivity to radiation as cells are most radio-resistive in both 
these situations 20. It is therefore reasonable to suggest that a synergism ought to exist 
when combining ionising radiation with hyperthermia. As with most therapies, 
sequencing for such a combined approach is vital. Deciding whether hyperthermia is 
to be applied prior to or after the administration of ionising radiation greatly depends 
on understanding the underlying cell-killing mechanisms by both these modalities.  
Firstly, hyperthermia kills cells both directly and indirectly 27. The ‘direct’ 
cell-killing mechanism acts by denaturing proteins, inactivating vital enzymes, 
disrupting transport mechanisms and ceasing mitochondrial function within the cell 28. 
This mode of action is reasonably well understood and most profound if higher 
temperatures are used. For example, Nikfarjam et al., reported that direct cell-kill is 
observed by the inactivation of vital enzymes in the range of 42-45ºC for periods of 
30 to 60 minutes, yet between 60 and 140ºC protein denaturation is observed 29. The 
‘indirect’ cell-killing mechanism from hyperthermia is not as well understood and is 
regarded as a progression in cellular injury. This progression is thought to take place 
due to altered apoptosis mechanisms, cytokine release, vascular injury and a 
mechanism known as Kupffer cell activation 28,29.  
The exposure time to hyperthermia, or the duration of a heat-treatment, is also 
an issue that needs to be considered. After all, the same cell-killing effect can possibly 
be achieved by using a lower temperature applied for a longer period compared to a 
higher temperature for a short period 30. How this concept was applied in this thesis 
will be further discussed in the next chapter.  
Overall, hyperthermia targets the cytoplasm of the cell and everything within 
it apart from the nucleus of the cell. This, again, contrasts the effects that x-ray 
radiation has on a cell, since approximately one third of the radiation will target the 
DNA in the nucleus directly, and the other two-thirds will create free radicals within 
the cytoplasm 20. This, in turn tries to destroy the chromosomes in the nucleus of the 
cells. The main mode of cell death from radiation is believed to result from the 
interaction of two DNA double strand breaks within the nucleus of the cell 31. Single 
strand breaks can also lead to cell death but have a higher chance of being repaired. 
Studies have shown that the greatest synergistic effect between ionising radiation and 
hyperthermia, at lower temperatures, occurs when hyperthermia is administered after 
the radiation, with the best effect if administered directly after 19,23,32-34. The principal 
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reason for this is that hyperthermia inhibits cellular repair mechanisms in cells that 
have only suffered sublethal damage from the radiation, or single strand breaks. There 
have been suggestions that this combined effect is additive if not supra-additive, yet 
the disputes between researchers regarding this issue seem to reflect the different cell-
lines and/or methodologies used 34-36. 
It is interesting to note that fractionating hyperthermia is not beneficial due to 
the development of thermotolerance 36. Thermotolerance is the change in cellular 
sensitivity to succeeding heat treatments produced by the initial thermal dose 24. This 
resistance is mainly developed by heat shock proteins 37,38. Studies have suggested 
that in a fractionated radiation scheme only one heat treatment, or a maximum of two, 
is to be incorporated into the overall treatment scheme of patients 36,39. This then 
avoids the problems from thermotolerance and ensures the patient receives the 
benefits from this combined approach. In this study, the development of 
thermotolerance is of no concern since both the radiation dose and the heat-treatment 
are administered to the cells in a single fraction.  
At present, most hyperthermia treatments are administered to treat solid 
tumours such as head and neck, liver, renal, bone, prostate, lung, breast and adrenal 
cancers through the use of percutaneous ablation techniques 30,40,41. Of all 
percutaneous ablation techniques available, radiofrequency ablation is the most 
commonly used ablative therapy 42. Hyperthermia can also be administered as a 
regional therapy, in which deep-seated tumours of the pelvis and abdomen are treated. 
Regional hyperthermia has also been combined with chemotherapy to manage 
patients with soft tissue sarcomas 43. Regional therapies can be administered using the 
Sigma-60 applicator as described by Wust et al. 44.  
The applications of whole body hyperthermia in the treatment of cancer have 
been investigated as early as the 1970s. Various methods of applying whole body 
hyperthermia, such as heating by the use of encompassing patients with hot wax 
(early technique) and heating by using the radiant heat device (current technique), 
revealed the various limitations of applying whole body hyperthermia 45. For instance, 
it is crucial to ensure that throughout the procedure, the patients fluid intake is 
continuously replenished to prevent severe dehydration 46. Toxic effects, such as 
damage to the liver from the elevation of liver enzymes, were found to occur if the 
whole body temperature exceeds 41.8ºC 47. Other reported side-effects below 41.8ºC, 
such as diarrhea, leg and arm edema, and fatigue are generally observed but are 
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usually resolved within 48 hours following treatment 48. More interestingly, whole 
body hyperthermia has been shown to suppress the immune system and hence might 
enhance the effects from chemotherapy in the treatment of leukaemia 49. In this thesis, 
however, only the combined effects from radiation and hyperthermia in the treatment 
of leukaemia, on an in vitro scale, will be considered. 
 
1.3 AIM OF RESEARCH 
 
The aim of this research was to carry out basic in vitro experiments using a 
mouse leukaemia cell line in order to gain a fundamental understanding a supra-
additive effect occurs when combining ionising radiation, as used in TBI procedures, 
with mild hyperthermia. Several experiments were carried out to investigate the 
cellular response to radiation, mild hyperthermia and a combination of both these 
regimes. It was hoped that from these experiments a model could be constructed that 
incorporates the radiation dose plus the ‘heating dose’ in order to predict the cell 
survival of leukaemia cells. An extensive literature review did not reveal any 
published papers that construct such a model for leukaemia cell lines.  
In order to achieve this aim, a framework for the experimental set-up at the 
University of Canterbury for the undertaking of radiation biology experiments needed 
to be established. Never before have such experiments been performed at the 
University of Canterbury and hence there not all facilities are in place to carry them 
out. For radiation biology experiments, one typically requires a biohazard safe room 
for the growing, maintaining and measurements taken of the cell line and a linear 
accelerator (linac) for the administration of radiation doses. Preferably, both the linac 
and the biohazard safe room are found on the same premises for various reasons such 
as the concerns that the Ministry of Agriculture and Fisheries (MAF) have about the 
transport of bio-hazardous material. Such facilities however, are not currently 
available at the University of Canterbury and collaboration was sought with both the 
Department of Chemistry and Christchurch Hospital to enable this study to be carried 
out.  
The Department of Chemistry at the University of Canterbury has a biohazard 
safe room used for experiments utilising a mouse leukaemia cell line and were willing 
to make these available for this project. To handle this cell line, however, one must be 
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biohazard level 3 qualified as per MAF regulations, resulting in the necessary full 
cooperation of a highly competent and qualified technician. Approval for this project 
by both the head of the Department of Chemistry and the Chemistry technician were 
eventually obtained. 
After some investigation, it was found that the Research Department at 
Christchurch Hospital had access to human leukaemia cell lines. Unfortunately, after 
some inquiries it was found that these cell lines would be unavailable throughout the 
duration of this project. Hence, the mouse-leukaemia cell line was the only cell line 
investigated throughout this study. 
The Department of Oncology at Christchurch Hospital was approached with 
the request for the utilisation of one of their linear accelerators in order to deliver 
radiation doses to the cells throughout the project. The principal medical physicist 
approved this request but of course laid restrictions as to ‘when’ the linac was to be 
used since patients will always come first. This resulted in 6 a.m. visits to the 
technician in the Department of Chemistry to receive the cells ready for transportation 
to the Hospital, to arrive there around 7 a.m. for the administration of radiation doses 
under the supervision of a medical physicist. Hence, a high level of commitment to 
the project was required from both the technician and the medical physicist 
concerned. Logistical problems, throughout this study, were incurred due to the need 
for MAF approval to transport the cells to and from the hospital, and the lack of 
several required resources to carry out these experiments.  
 In this thesis, the experimental set-ups used are discussed in Chapter 2: 
Materials and Methods; the results and data are analysed in Chapter 3: Results and 














2.1  THE LEUKAEMIA CELL-LINE 
 
The cell-line used throughout this investigation was the P388 D1 (Murine 
Leukaemia cells) American Type Culture Collection (ATCC), Manassas, USA, CCL 
46. This cell-line was originally obtained from ATCC on the 28th of March 2002 for 
different experiments under the Ministry of Agriculture and Forestry (MAF) permit: 
2002014613. The intrinsic properties of this cell-line, such as the cell doubling time 
are shown below in table 2.1. It is interesting to note that this type of cell-line cannot 
be plated. This means that it is not possible to perform a clonogenic assay, as is most 
commonly done to determine the surviving fraction of cells after irradiation that 
enables the production of a cell survival curve 20. In a clonogenic assay, one is able to 
count the surviving colonies that exist after exposure to radiation. Such an assay 
therefore, really is a measure of cell viability as the assay assesses the reproductive 
integrity of the cells.  
 
Cell doubling time Approximately 10-12 hours 
Natural ‘lifetime’ of the cells Approximately 7-10 days 
Type of culture Stationary suspension culture 
Plating efficiency Cannot be plated 
 
 
Table 2.1: The intrinsic properties of the P388 D1 Murine Leukaemia cell-line. 50. 
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Since a clonogenic assay could not be performed, it was decided to carry out a 
cell proliferation assay. A cell proliferation assay determines the inhibition of cell 
growth, or direct cell-death, rather than looking at long-term reproductive integrity. 
For this assay, a WST-1 Rapid Cell Proliferation Kit was bought from Merck, 
Palmerston North, New Zealand. WST-1 is a reagent (dye) used for the colorimetric 
quantification of cell viability and proliferation. It measures the metabolic activity of 
mitochondria within the cells to determine whether the cell is still viable. This dye 
however, must be used within a 96-well plate set-up, as shown in figure 2.1, in order 
to measure the cell viability. The counter used for this does not accept any other 
plates.  
 To be able to interpret any results obtained using this cell-line, it is vital to 
understand the environment in which the cells live; or in other words, how they are 
grown, maintained and seeded in experiments. The cells are maintained in large, 
plastic, tissue culture flasks, also known as stock flasks, and are grown in a growth 
medium that consists of the following: 
 
            minimal essential media 
            10% foetal calf serum                                          (protein source) 
            266 units of penicillin per mL                                (antibiotic) 
            132 µg streptomycin per mL                                   (antibiotic) 
            2 mM L-glutamine                                                (amino-acid source)  
            2.2 g/L sodium bicarbonate (NaHCO3)  
            7.4 mM hepes.  
 
Furthermore, the cells are normally grown in a 5% carbon dioxide (CO2) environment 
that, along with the sodium bicarbonate and the hepes, stabilise the pH of the medium 
to about 7.5. The cells are kept in a continuous growth phase by the method of 
‘splitting’ on a weekly basis. ‘Splitting’ is the tipping out of roughly 80% of cells in 
media and adding 80% new growth medium. This ensures that the stock of cells in 
culture is always actively growing, as they never seem to run out of growth medium. 
In all experiments, cells were initially seeded from an actively growing stock flask 
into a 5% CO2 environment and were incubated overnight with the exposure to 
hyperthermia, radiation or both occurring on the following day. 
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The radiation doses to the cells were given using a linear accelerator at 
Christchurch Hospital. Because of this, travelling to the hospital from the University 
of Canterbury did not allow the cells to be continuously exposed to CO2. As this 
condition therefore could not be applied in all experiments at all times, it was decided 
to eliminate any use of CO2 after the initial incubation time of the cells. A test-run 
revealed that without this controlled exposure to 5% CO2, the pH of the cells increase. 
This increase in pH creates an alkaline environment causing the cells to die. It thus 
became very important to be able to trap the carbon dioxide that the cells were 
initially exposed to into the cell environment, done simply by closing the system from 
any airflow. Such entrapment was found to create a stable pH environment for the 
cells, allowing them to survive. The 96-well plate set-up, initially considered for the 
experiments, could not be sufficiently closed off to prevent air exchange from 
occurring and it was for this reason that the experimental set-up changed to the use of 
small culture flasks, as shown in figure 2.1. Due to this change, it was not possible to 
use the WST-1 dye, since the dye requires the 96-well plate set-up. Hence, 
determining the cell viability by assessing the mitochondrial changes within a cell was 
not achievable.  
 
        
 
Figure 2.1: Left: A 96-well plate sealed with a rubber seal that still allowed for air 
exchange. Right: An empty culture flask that was used to replace the plates as the 
flask caps screw tightly shut to hold the carbon dioxide inside the flask.  
 
2.2 DETERMINING CELL VIABILITY 
   
 Since the logistics of this project prevented the use of WST-1 dye, or any 
other dye for that matter, a simpler method was employed to determine cell viability. 
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The Coulter counter Model ZF (Coulter Electronic Limited, Luton, England) 51 can 
determine whether a cell is dead or alive by measuring the spherical diameter, or 
volumetric size, of the cell. In general, a dead cell shrinks considerably in comparison 
to their living counterparts. It becomes obvious that by measuring the size of the cell 
to determine its viability we are ignoring other vital information that could also 
indicate the cell is dead. For example, when using the WST-1 dye, the metabolic 
activity of a cell would show that the cell is no longer viable. Yet when the same cell 
is passed through the Coulter counter, it could be indicated as alive, as the cell has not 
shrunk enough to be distinguished from its truly alive counterparts. Hence, the 
Coulter counter only takes a ‘snapshot’ of the cells to determine its viability and does 
not allow for the delayed cell death or loss of reproductive integrity to be measured. 
Because of this, the cell-kill by hyperthermia, radiation or both as measured by the 
Coulter counter is most likely underestimated.  
 
2.2.1 THE COULTER COUNTER 
  
 An aliquot of 1 mL is initially taken from the culture flask and diluted into 10 
mL of Isoton II, an electrolyte solution. Once completely mixed, half a milliLitre of 
this new solution is passed through the aperture of the Coulter counter, which has a 
tube orifice of 100 microns. Electrodes on either side of this aperture induce a current 
path between them. Hence, whenever a cell passes through the aperture, the 
electrolyte is displaced, resulting in a change in the resistance between the two 
electrodes. This in turn produces a voltage pulse whose magnitude is directly 
proportional to the volumetric size of the cell producing that change. The voltage 
pulse is consequently fed into a threshold circuit that discriminates between dead or 
alive cells by passing the count pulses only for the cells that exceed the threshold 
level 51.  This threshold level was determined by comparing the cell count known 
from a haemocytometer, another instrument used for the counting of cells in a 
solution, to that of the Coulter counter. The threshold is set by changing the ‘aperture’ 
and ‘threshold’ settings on the machine, (see schematic diagram in Appendix A), and 
were set to 32 and 43 respectively. This was done on a trial and error basis, resulting 
in these values coinciding with the measurements as obtained from the 
haemocytometer in previous experiments performed in the Chemistry Department. 
The level of sensitivity was set to one, the highest value available. It should be noted 
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that the calibration of the Coulter counter was done years before this thesis 
commenced, and could not be redone since it was also simultaneously used for other 
experiments in the Chemistry Department. In addition, the settings on the Coulter 
counter are very arbitrary, as the values indicated above do not have any units 
associated with them. The uncertainty in the Coulter counter was found to be 
negligible when it was first calibrated and has since been ignored 52.  
The total pulse count measured by the Coulter counter represents one tenth of 
the number of viable cells per half a millilitre. To obtain the number of viable cells 
per millilitre the total pulse count is simply multiplied by twenty. It should be noted 
that living cells are counted, resulting in an indirect measure of cell-kill. In fact, the 
experiments arguably determine the growth inhibition of the cells rather than direct 
cell-death. Throughout this thesis, however, it will be referred to as cell-death. 
 
2.2.2 CONTROL GROUPS AND UNCERTAINTIES 
 
 Every culture flask used throughout this study contained an initial 15 mL of 
cells in media, allowing approximately 10 readings to be taken from each flask, as 1 
mL is needed per reading with the extra 5 mL ensuring that the cells have enough 
media when the last reading is taken for all experiments performed in this thesis. 
These readings were taken over a period of a week, and for each week of experiments, 
data from at least one control group were obtained. This was done to ensure that each 
control group was obtained from the same actively growing stock flask as the other 
cells in separate culture flasks receiving hyperthermia, radiation or combined 
treatments. The control groups were continuously maintained at 37.0 ± 0.1 ºC and had 
measurements of cell-death taken at the same time as those cells in media undergoing 
hyperthermia, radiation or both. See Section 2.4 for the specifications of incubators 
used. 
The reproducibility of the initial culture flask set-up, in which cells are 
dispensed into small culture flasks from the stock culture flask, was tested by 
dispensing 15 mL of cells in media from the same stock flask into 10 separate culture 
flasks and taking a measurement from each at the same time. The mean Coulter 
counter reading from this was found to be 370916 cells/mL with a standard deviation 
of 8% (±25673). This uncertainty can be ignored since the analysis of the data 
obtained throughout these experiments only concerns itself with the relative growth 
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response to the control groups, rather than the response to every first measurement 
taken. Hence, a comprehensive analysis of the control groups is required and has been 
completed in Section 3.1. 
The reproducibility of the initial set-up as explained above was also found to 
vary by approximately 10% when compared on a weekly basis. In simpler terms, each 
week when cultures where dispensed from the stock flask it was found that a 
difference of 10% existed between the readings taken in separate weeks. The method 
of splitting creates this particular uncertainty in the measurements. A way to eliminate 
this uncertainty was to normalise all experiments in one week using the control group 
used in that particular week before comparing the results obtained in all weeks.  
The reproducibility of a single cell count measurement from one culture flask 
was also tested by dispensing 15 mL into a single culture flask and taking 10 
measurements from it at the exact same point in time. This variation resulted in a 
standard error of 10%. This uncertainty possibly arises from the cells still clinging to 
one another even after being vigorously shaken, thus disallowing an equal distribution 
of viable cells in media to be measured. This uncertainty could not be eliminated and 
was accounted for in the analysis. 
   
2.3 TRANSPORTATION PROTOCOL AND MAF APPROVAL  
 
 The original MAF approval for the cell-line when it was first obtained from 
the American Tissue Culture Collection indicates that the cell-line is classed as a 
Category A Infectious Substance, affecting animals only. Because of this, the cell-line 
was to be kept within the biohazard laboratory in the Chemistry Department at the 
University of Canterbury at all times. For this project however, the cells needed to be 
transported from the University of Canterbury to Christchurch Hospital and back. 
This was necessary so that a linear accelerator, in the Department of Oncology, could 
be used to administer the radiation doses. The logistics of this project therefore 
required approval from MAF. This approval was obtained through a formal proposal, 
which contained a transportation protocol that was approved by both a health and 
safety officer at the University of Canterbury and MAF as included in Appendix B.  
The transportation protocol required the cells in media to be housed in two 
leak-proof containers that were carried in a well-labelled chilly bin. Figure 2.2 shows 
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both the chilly bin and the containers. The flasks needed to be kept upright within the 
chilly bin at all times to prevent contamination of the flask-caps. Cotton wool was 
used to reduce movement of the flasks within the container and to serve as an 
absorbent medium if spillage were to occur. Seven culture flasks fit into the inner 
leak-proof container and, when housed by the outer container, allowed four such 
packages to be transported in the chilly bin (an insulated picnic cooler). One of these 
packages, however, contained a single separately packaged culture flask instead of 
seven as it was used as the control group. This control group therefore underwent the 
exact same travelling conditions as the groups receiving radiation. 
 
   
 
 
Figure 2.2: The chilly bin required some basic labels including the biohazard symbol 
and contact details of people involved in the case of accident or severe spillage. The 
containers on the right show how seven culture flasks fit into the inner container 
housed by the outer container. 
 
2.4 SET-UP PROCEDURE FOR HYPERTHERMIA EXPERIMENTS 
 
The following set-up was employed to determine the cell-kill from 
hyperthermia alone. The cells dispensed in their culture flasks after overnight 
incubation, as described in Section 2.1, were exposed to various regimes and different 
levels of hyperthermia in several incubators. All the incubators used (models: CAT 
7050-7150 and CAT 1050-1400 manufactured by Contherm, Lower Hutt, New 
Zealand) regulate temperature to within 0.1ºC and allows for heat settings in the range 
of the ambient room temperature plus 5ºC up to 100ºC 53. 
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In the initial experiments conducted the cells were exposed to a temperature 
range of 37–43ºC, in intervals of 1ºC, with one batch exposed to 50ºC. The lower 
temperatures provide data on the mild hyperthermia range whereas the 50ºC 
investigates hyperthermia at a more extreme level. The exposure times used for each 
temperature were 30 minutes and 1 hour to mimic a practical clinical setting, along 
with 2- and 3-hour long exposures used to determine whether the effects of 
hyperthermia were more pronounced by increasing the exposure time. For logistical 
reasons, the heat treatments were carried out approximately 22 hours after the seeding 
of the cells. Measurements of cell survival were taken as indicated in table 2.2, 
resulting in 10 readings taken over the span of a week. Due to logistical reasons, 
measurements could not be obtained at night or on weekends. It should be noted that 
the exact time of each measurement was recorded and was corrected for in the results. 
After these results were analysed, it was also decided to expose the cells to 
hyperthermia regimes of 44, 45, 46, 47, 48 and 49 degrees Celsius due to various 
reasons as outlined in Chapter 3. 
 
Measuring Cell-Survival 
Day Time of measurement Notes 
Monday Morning Original number of cells seeded 
Tuesday Morning Number of cells present after 
incubation time 
Tuesday Directly after 
heat treatment and  
late afternoon 
Measuring cell-survival 
Wednesday Morning and 
late afternoon 
Measuring cell-survival 
Thursday Morning and 
late afternoon 
Measuring cell-survival 
Friday Morning Afternoon measurement was not 
possible 
Saturday & Sunday None Could not measure on these days 
Monday Morning Last measurement of cell-survival 
 
Table 2.2: Measurements of cell survival were taken on a regular basis.  
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2.5 IRRADIATION SET-UP 
 
 The linear accelerator in Treatment room 3, Oncology, at Christchurch 
Hospital was used to provide the radiation doses to the cells contained as outlined in 
Section 2.3 above. A standard dosimetry check was initially performed to determine 
the output of the linac (Section 2.5.1). Solid water with a thickness of 10 cm was 
placed on the treatment table with the containers holding the flasks placed on top in 
an upright position. The solid water and the containers were centred on the treatment 
table by both the light field produced for a 25 cm x25 cm field size and by using the 
optical lasers. This ensured that the reproducibility of the set-up method for all 
containers to be irradiated was both consistent and accurate. The gantry of the linac 
was placed at 180º with the collimator rotated to 90º, resulting in a source to skin 
distance (SSD) of 100 cm. Irradiation thus took place from underneath the treatment 
table as can be seen in figure 2.3 below. The carbon fibre treatment couch has an 
absorption factor of less than 1%. This factor was ignored throughout the rest of the 




Figure 2.3: Irradiation set-up showing the cells in their pinkish media. Note how 
seven flasks were irradiated at once. 
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 The above set-up was calibrated using thermoluminescent dosimeters (TLDs) 
that were attached to the bottom of each flask as outlined further in Section 2.5.2 
below. 
 
2.5.1 DETERMINING THE OUTPUT OF THE LINAC 
 
 The nominal photon energy as used by this linear accelerator was 6 MV. 
Before performing the calibration of TLDs, a standard dosimetry check was carried 
out. For this dosimetry check, the field size of the linac was set to 10 cm x10 cm 
along with a source to skin distance of 90 cm, a measurement depth of 10 cm and with 
10 cm of solid water as backscatter material. The Baldwin-Farmer dosimeter, 
consisting out of a Farmer chamber and an electrometer, was used to determine the 
output of the linac. The Farmer chamber provides a stable and reliable standard for x-
rays of all energies in the therapeutic range 31. This chamber was connected to an 
electrometer that measures the ionisation charge. This reading was subsequently 
corrected for both the pressure and temperature of the room 7. The output of the linac 









Where Rav is the average of three readings taken from the electrometer and Fcal is the 
chamber calibration factor. 200 monitor units were delivered to check the output of 
the linac. This output was determined to be 0.997 cGy/MU, which is very close to   
1.0 cGy/MU as expected and has been carried through all subsequent dose 
calculations. 
 
2.5.2 TLD CALIBRATION  AND MEASUREMENTS OF DOSE 
 
 TLDs were chosen for the calibration of the irradiation set-up, as they were 
readily available at Christchurch Hospital and inexpensive. The phenomenon of 
thermoluminescence is observed when a crystalline material, such as lithium fluoride 
(LiF), releases both absorbed energy and energy trapped from irradiation as visible 
photons through heating the material 6. The heating of the material, also known as the 
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heating cycle, occurs in a planchet and the visible light emitted is measured by a 
photomultiplier tube (PMT). The PMT converts the light into an electrical current that 
is subsequently amplified and then measured by an electrometer. The heating of the 
material occurs over a range of temperatures resulting in the formation of a glow 
curve that can be correlated to the dose given through proper calibration methods. The 
most common crystalline material used for clinical dosimetry is LiF that requires a 
trace amount of impurities to induce the thermoluminescent phenomenon. In this 
study, lithium fluoride with both magnesium and titanium impurities (LiF:Mg,Ti) 
were used. These TLDs, also known as the Harshaw TLD-100, have a size of 3.2 mm 
x 3.2 mm x 0.9 mm and display a main peak in the glow curve in the temperature 
range of 180º to 260 ºC.  
The average calibration factor for the TLDs was determined by placing three 
calibration TLDs in a standardised set-up, with a field size of 10 cm x10 cm, and 
exposing them to 200 MUs. The calibration TLD readings, multiplied by each 
individual TLD’s sensitivity factor, were used to determine the calibration factors as 






=  (2) 
 
From this, the average calibration factor was determined to be 0.015 cGy. TLDs were 
then placed underneath each of the seven culture flasks, as it was not possible to place 
them accurately inside due to the bottleneck shape of the flasks. Underneath was thus 
the closest place to where the cells would actually be. All of the culture flasks were 
filled with 15 mL of water to mimic the cells in media. These flasks were put into the 
leak-proof containers with cotton wool and set-up on the treatment table as seen in 
figure 2.3 above. The whole set-up was exposed to 200 MUs. Each TLD reading was 
corrected by the average calibration factor to obtain the actual dose to which each had 
been exposed. This procedure was repeated twice to observe the variability in dose 
with reproduction of the set-up. The depth dose variation was also determined, with 
15 mL of cells in media mimicking a distance of 2 cm in water. 
The average dose given to the first batch of TLDs was found to be 163 cGy 
with a standard deviation of 1.9 cGy (1.2%). The second batch received an average 
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dose of 150 cGy with a standard deviation of 3 cGy (2%). It is known that the 
intrinsic uncertainty in LiF TLDs lies in the range of 3-5% and this variation is 
therefore within the expected range 55. Other factors that contribute to this difference 
of dose measurements in both batches are the uncertainties found in the spatial 
variation of the dose given to the TLDs and the reproducibility of the set-up. To 
determine the overall uncertainty, the TLDs of both the first and second batches in the 
same position were compared and averaged. Over both batches of TLDs in the same 
positions, it was found that the average dose given was 157 cGy with a standard 
deviation of 7.8 cGy (5%). The depth dose variation for the 2 cm of cells in media 
was found to be less than 0.3% and deemed negligible. Hence, the total uncertainty in 
the dose as determined by TLDs was found to be 9%, of which 4% was taken as the 
intrinsic uncertainty of the TLDs and the other 5% results from both the spatial 
variation of the radiation and the reproducibility of the set-up used.  
The overall factor used to determine the number of MUs to be given to cells in 
media in subsequent experiments was 157 cGy/200 MUs, or in other words, 127 MUs 
for every one Gray administered. This factor can be regarded as rather low, but since 
backscatter material was not used to increase the overall dose administered, it can be 
considered sensible. Backscatter material in the form of rice bags was originally 
considered for this project but was not used since they complicated both the 
reproducibility and the stability of the set-up. It was later realised that perhaps a tank 
of water surrounding the set-up would have been ideal as backscatter material. The 
obvious problems with a tank of water of course are the possibilities of leaks in the 
plastic containers and the floating of these containers. Such problems could have been 
overcome if more time was available for the completion of the project. At the stage of 
realisation, however, over half of the experiments had already been completed and 
consistency was considered as more important. 
  
2.6 COMBINING RADIATION WITH HYPERTHERMIA 
 
 The radiation set-up, as outlined in Section 2.5, allowed seven flasks to be 
irradiated at the same time with the same number of MUs resulting in the same dose 
with an uncertainty of 9% as determined in Section 2.5.2. From a logistical point of 
view, it made sense to use one of these flasks to observe the effects from radiation 
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alone and subsequently expose the other six to various regimes of hyperthermia, thus 
resulting in combined regimes. The levels of radiation that the cells received were 1, 
3, 5, 9, 11 and 15 Gy. The various regimes of hyperthermia were administered to the 
six flasks, back at the University of Canterbury, after the radiation had been applied 
using the same methods as described in Section 2.4.  
The temperatures used for the hyperthermia regimes were chosen to be 41 and 
42 degrees after a literature review revealed that whole-body hyperthermia in humans 
can only be safely administered up to a maximum temperature of 41.8ºC as described 
in Chapter 1. These temperatures were applied for 30 minutes, 1 hour and 3 hours. 
The 30 minute and 1 hour exposure time was used to mimic a treatment time that 
would be practical in a hospital setting. The exposure time of 3 hours was merely 
chosen to observe how the increase of exposure time changes the results of the 
combined treatment. It should be noted that the time between the radiation treatment 
and subsequent hyperthermia treatment was approximately one hour on average. 
According to the literature review as discussed earlier, this time should be as short as 
possible to observe the greatest synergistic effect between hyperthermia and radiation. 
Both the transportation logistics and MAF requirements in this project prevented any 
reduction in this time between treatments and resulted in an inconsistent travel time 
between the hospital and the university that ranged between 20-30 minutes.  
 Measurements of the control group, which underwent the same travelling 
conditions, and the cells exposed to both radiation alone and the combined regimes 
were made in the same way as for hyperthermia alone. The radiation treatment, 
however, could only be applied on Wednesday mornings and therefore delayed the 
experiments by a day. Table 2.3 indicates when measurements of cell-survival were 
taken of the cells that had undergone either radiation alone or a combined treatment of 
radiation and hyperthermia. Again, the exact time of each measurement was recorded 
and was corrected for in the results. It should be noted, however, that the ‘directly 
after’ measurement for radiation exposures and those combined with hyperthermia 
were taken approximately one to four hours after the exposures were completed, due 






Day Time of measurement Notes 
Tuesday Morning Original number of cells seeded 
Wednesday Morning, directly after 
radiation and/or  
heat treatment  
and late afternoon 
The morning measurement gives the 
number of cells present after the 
incubation time 
Thursday Morning and 
late afternoon 
Measuring cell-survival 
Friday Morning and 
late afternoon 
Measuring cell-survival 
Saturday & Sunday None Could not measure on these days 
Monday Morning Last measurement of cell-survival 
 
Table 2.3: Measurements of cell survival were taken on a regular and reproducible 
basis for all experiments conducted. 
 
 
2.7 STATISTICAL METHODS 
 
 The two statistical methods used throughout this thesis were the unpaired 
student t-test and the analysis of variance (ANOVA). Both statistical tests were 
performed using Statview 4.0 for the Macintosh computer by Abacus Concepts, 
Berkeley, USA. It is important to understand how these tests work so that the results 
from them can be interpreted correctly. Section 2.7.1 deals with the unpaired student 
t-test and Section 2.7.2 with ANOVA. 
 
2.7.1 UNPAIRED T-TEST 
 
The t-distribution is a probability distribution used when the mean of a 
normally distributed population is estimated for a small sample size 56. This 
distribution is the basis for performing an unpaired t-test in which the statistical 
significance between two sample means is found 56,57. In simple terms, an unpaired t-
test is used when two groups undergoing different conditions are compared. One 
example of this, as applied in this project, is the comparison between cells that have 
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undergone hyperthermia at 40ºC and those that underwent hyperthermia at 41ºC. 
Essentially two different populations exist that are being compared in terms of their 
means. The null-hypothesis tested is that the two population means are the same, and 
hence that there is no difference between the two groups. This test produces a 
probability value, known as a p-value that indicates whether the two population 
means are significantly different. Throughout this thesis, significance will be assumed 
to be for p-values less than 0.05, meaning that there is less than a 5% chance that the 
two population means are the same.  
 
2.7.2 ANALYSIS OF VARIANCE 
 
 The analysis of variance tests for the heterogeneity of the mean differences 
between several populations, based on samples taken from each population 58,59. It is 
very similar to the unpaired t-test described above where two population means are 
compared. In the analysis of variance, however, multiple population means can be 
compared with the null-hypothesis being that all population means are the same. 
Again, p-values are produced in this test to indicate how different each group is from 
one another. In the hyperthermia experiments, for example, one of the hypotheses to 
be tested is whether there is indeed a statistically significant effect from applying heat 
to the cells in comparison with the control groups. This requires an analysis of 
variance since the means of the control groups will be compared to the means of 
groups that underwent different parameters, such as groups exposed to 38 degrees and 













3.1  INITIAL BASIC ANALYSIS AND CONTROL GROUPS 
 
 Over the span of several weeks of data collection, eleven 37ºC control groups 
were obtained of which four underwent the travelling conditions to and from 
Christchurch Hospital. These four control groups were used to find the cell death 
relative to 37ºC of cells undergoing radiation or combinations of radiation and 
hyperthermia. The other seven control groups are indicators of how the cells normally 
proliferate in a stable environment and were used to find the cell death relative to 
37ºC of cells undergoing hyperthermia only.  
For every dataset obtained throughout this project a second order polynomial 
was fitted using the Matlab 7 software package. Normally, cell growth is considered 
to be exponential and hence, an exponential fit is often more appropriate. An 
exponential fit however is only warranted if the cells are allowed to grow with a 
sufficient amount of media to fuel such an exponential growth. In our case, such 
growth was restricted by the amount of media present and hence, the cells eventually 
ran out of nutrition and died. The logistic function, in the form of an S-shape, models 
this situation accurately as seen in figure 3.1. The initial exponential growth is 
observed followed by a slowing down as the cells run out of media. In our 
experiments, it was found that the initial number of cells seeded, on average being 
4x105 cells/ml, was so large that the initial exponential growth on the logistic curve is 
not seen. The second part of the graph after the exponential growth can be modelled 





Figure 3.1: The logistic function. 
 
Due to restrictions on our data acquisition of only being able to record two 
data points per day, as explained in Chapter 2, it was found that a second order 
polynomial fits the data better than a log function. Recall that all the data obtained 
contains an uncertainty of 10% due to the method of splitting as discussed and 
determined in section 2.2.2. An example of how well a second order polynomial fit 
one control group of the 37-degree data is shown in figure 3.2, with the 10% 
uncertainty shown by the uncertainty bars. 
 
 
























Figure 3.2: The second order polynomial fit to one of the 37-degree control groups 




The second order polynomial fit, applied using Matlab’s polyfit command, was used 
throughout this thesis as a means of presenting the data. These plots were generated 
for all datasets and it was found that a second order polynomial models the data 
accurately.  
 
3.1.1 ANALYSING THE CONTROL GROUPS 
 
 As indicated earlier, there are two different sets of control group data to 
consider; namely, the control groups that travelled to and from Christchurch Hospital 
and those that remained in their stable 37-degree environments at the University of 
Canterbury. The seven control groups that remained, consisted of data taken over five 
different weeks. In this group of seven, three lots of control group data were acquired 
in a single week whilst the other four groups were all acquired in individual weeks. 
The data of those control groups that ‘travelled’ however were all taken in individual 
weeks. Figure 3.3 shows the compilation of both sets of control group data side by 
side with their averages calculated.  
 











































Figure 3.3: The normalised cell counts of the normal 37-degree control groups (left) 
are more spread out than those of the groups that travelled (right). 
 
It should be noted that it seemed reasonable to average the three sets of data acquired 
in a single week of the normal control groups, as they were close together, and hence 
only five curves, instead of seven are drawn. The uncertainty bars and data points on 
these plots have been removed for reasons of clarity.  
 The real question to be answered, however, is how do the two different types 
of control groups compare? Is there a statistical significant difference between them 
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or does the travel to and from the hospital have little or no effect? Figure 3.4 was 
generated to get some insight into the answers to these questions. 
 



























Figure 3.4: Comparison of the travelling and ordinary control groups.  
 
 It should be noted that figure 3.4 only shows the cell growth up to 58 hours 
since the control groups that were exposed to travelling conditions only had 
measurements taken over a period of three instead of four days when compared with 
the ordinary groups. This is due to the logistical restrictions that were applied when 
obtaining data for cells that underwent radiation exposures.  
Figure 3.4 seems to indicate an obvious difference between the travelled and 
the ordinary control groups. A statistical unpaired t-test, however, was performed to 
test whether this difference was statistically significant. Recall that the null hypothesis 
used in an unpaired t-test assumes that the means of the two datasets are the same. A 
p-value of 0.07, however close to 0.05, was found confirming the null hypothesis and 
thus there is no statistical significant difference between the two control groups. It 
should be noted the cells were only out of their incubators for approximately 2 to 3 
hours. Hence, it is not surprising to find that the travelling conditions made no 
statistically significant difference to the growth rate of the cells. Also, the visual 
difference that is seen might be an indication that by the vibration of the car, gases are 
vibrationally dispensed into the medium resulting in a slightly better growth rate. 
 Before analysing the data obtained from the cells exposed to hyperthermia, 
radiation or a combination of both, one must consider whether it is reasonable to 
average all the control group data. One could argue as to whether this average can be 
used to generate the relative response of the cells to radiation, hyperthermia or a 
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combination of both, or if the week-to-week individual datasets are to be used for this. 
The argument in favour of averaging is, that because there is no statistical significant 
difference between the groups and the variation in each individual dataset is small 
(10% standard deviation) it is reasonable to average all the individual control groups 
together. By averaging, the overall noise found within the control groups is also 
reduced. The argument against, however, debates that the individual control groups 
are representative of all the data taken in one week and model the natural growth rate 
occurring in each week more accurately. It can also be said that uncontrollable outside 
influence parameters change on a weekly basis, such as air humidity, and we do not 
know what this effect has on those cells that underwent hyperthermia and/or radiation 
exposures. In addition, when looking at figure 3.4, the difference between the two 
groups is reasonably large, even though not statistically significant. Hence, it is 
argued that all the data should be corrected for on a week-to-week basis rather than on 
an ‘averaged’ basis. Since both arguments are very reasonable it was decided to 
compare all the data obtained throughout this thesis, visually through a graphical 
analysis, in terms of both arguments. This comparison showed that the trends were the 
same using either method. Hence, after careful consideration the convention of 
correcting on a weekly basis was adopted, so that uncontrollable parameters can be 
accounted for.  
 
3.2 HYPERTHERMIA EXPERIMENTS 
 
 The initial hyperthermia experiments consisted of the temperature range of 38-
43 and 50 degrees, for exposure times of 30 minutes, 1, 2 and 3 hours. Soon after 
these datasets were acquired, it was also decided to perform the same experiments in 
the temperature range of 44-49 degrees. This was done to obtain a more complete set 
of data but mainly because the lower temperatures showed little to no cell kill, as can 
be seen in the analysis of them. Figure 3.5 contains four plots of the normalised cell 
count relative to 37ºC for all levels of hyperthermia per exposure time. 
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 b)  
 
Figure 3.5: The above plots show the effects of various levels of hyperthermia for a) 
30 minutes and b) 1 hour. 
30 minute exposures 
1 hour exposures 
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 c)  
 
 
 d)  
 
Figure 3.5 continued: The above plots show the effects of various levels of 
hyperthermia for c) 2 hour and d) 3 hour exposure times.  
 
On these plots 37ºC, even though not plotted, can be visualized as a horizontal line 
through the y-value of one. For reasons of clarity, the individual data points and 










































2 hour exposures 
3 hour exposures 
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uncertainty bars are not shown. It is obvious from the graphs that lower temperatures 
in the range of 38-43 degrees have little or no effect, which is why data for the range 
of 44-49 degrees was also acquired. Only 43 degrees appears to be breaking away 
after a 3-hour exposure from the low temperatures that cluster around the y-value of 
1, or in other words cluster around the 37 degree control group. The higher 
temperatures, ranging from 44-50 degrees, seem to show the same effect for all 
exposure times with 44 degrees joining this group more clearly after one hour. The 
extreme level of hyperthermia applied at 50 degrees shows virtually no change in the 
level of cell kill over the various exposure times. Considering 50 degrees, it was 
found that the lowest cell fraction after about 72 hours, was 0.2, meaning that 
approximately 80% of the cells were killed. 
 
3.2.1 ARRHENIUS PLOT 
 
 An Arrhenius plot can be used to ensure that no systematic error is present 
within the hyperthermia datasets. In an Arrhenius plot, one graphs the inverse of 
temperature on the abscissa against the natural log of the reaction rate, with a straight 
line confirming that there is indeed no systematic error. In our case, this reaction rate 
is simply the cell count at a single point in time. The point in time chosen for this plot 
was 72 hours as this is where all curves, in figure 3.5 a–d, are most divergent  
 




































Figure 3.6: The Arrhenius plot for the average of all data points of each temperature 
taken at 72 hours after the exposure to hyperthermia. 
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 All data for each temperature, regardless of exposure time, at 72 hours was 
averaged so that one single data point exists for each temperature level, as seen on 
figure 3.6. The Arrhenius plot does indeed follow a straight line and thus indicates 
that there was no systematic error in our data. Please note, that the values for 37 – 43 
degrees all cluster around the same level confirming that there is indeed no difference 
between them and that hyperthermia has little or no effect at these levels. 
 
3.2.2 STATISTICAL ANALYSIS OF HYPERTHERMIA DATA 
 
 An analysis of variance was performed, in which the means of all datasets 
tested are assumed to be the same, to determine whether there is a statistically 
significant difference in the data due to the exposure time. Only in the case of 30-
minute exposures was a statistically significant difference found, p-value less than 
0.05. The 30-minute data however, was found to be exceedingly noisy and this 
difference is hence attributed to the level of noise present. Hence, the exposure times 
that we tested, have no effect on the level of cell kill from hyperthermia. An analysis 
of variance also revealed that the level of cell kill was indeed dependent on 
temperature, as the means between the control groups and the data exposed to 
different temperatures were statistically significantly different with a p-value less than 
0.01. 
 An unpaired t-test was also conducted which compared every dataset with 
respect to the temperature they had been exposed to. From this, it was confirmed that 
there is no statistically significant difference between 38-42 degrees and 37 degrees. It 
was found that 43 degrees is statistically significantly different from 37 degrees with a 
p-value less than 0.05 as suspected from figure 3.5. All other temperatures were 
statistically significantly different with p-values less than 0.0001. Appendix C 








3.3 RADIATION EXPERIMENTS 
 
 The cell killing effect of 1, 3, 5, 9, 11 and 15 Gy were observed. Initially only 
a single dataset for each of these radiation levels was obtained. After the initial set of 
combined experiments, it was decided to acquire more data of the 5 and 11 Gy 
radiation levels; reasons for this are given in section 3.4. Three extra datasets of both 
5 and 11 Gy were obtained resulting in four datasets for each of these two levels, with 
the other levels consisting of only a single dataset each. Figure 3.7, shows how almost 
all four individual datasets of both the 5 and 11 Gy groups follow similar trends and 
hence their averages were found. Only the 5 Gy dataset that was acquired in a 
different week seems to slightly deviate from the main trend. The cell kill found from 
radiation alone normalised with respect to the control group is shown in figure 3.7 
where 5 and 11 Gy are the averages as found in figure 3.6. Note that the data points 
and uncertainty bars were omitted on both figures 3.7 and 3.8 for reasons of clarity.  
 
 












































































Figure 3.8: Cell kill from various levels of  radiation. 
 
These graphs indicate that the cell kill from radiation follows the familiar and 
well-known pattern that higher levels of radiation constitute increases in the level of 
cell kill. The level of cell kill from all these radiation levels, however, is a lot lower, 
even though consistent, than what other cell experiments have shown 20. It is believed 
that this is due to the limitations of our set-up and due to the Coulter counter, which 
underestimates the level of cell kill. It is interesting, however, to observe that the plots 
indicate an increase in the growth of the cells, relative to the control group, for both 1 
and 3 Gy. This is a possible indication that the hormesis effect, in which cell growth is 
encouraged by small amounts of radiation 60,61, might apply for this particular cell 
line. It should be noted that these experiments were not designed to test this effect and 
that since only one dataset for both 1 and 3 Gy is available conclusions in regards to 







3.3.1 STATISTICAL ANALYSIS OF RADIATION DATA 
 
 An analysis of variance found that there is a statistical significant difference 
between the radiation levels and the control groups, with a p-value less than 0.01, as 
expected. An unpaired t-test, which compared the cell kill effects of each radiation 
level to one another, found that there was no statistically significant difference 
between 0 Gy and 1, 3 and 9 Gy of radiation (p-values all above 0.05). This is not 
surprising as for all three radiation levels only a single dataset was obtained. All other 
levels were found to be statistically significantly different with p-values less than 
0.04. All p-values from the unpaired t-test can be found in Appendix C. These 
statistics cannot verify if a hormesis effect is seen for 1 and 3 Gy, as much more data 
is required to confirm such a hypothesis. 
 
3.4 INITIAL COMBINED EXPERIMENTS 
 
 It was initially decided to combine the levels of radiation as investigated in 
section 3.3 with hyperthermia at 41 and 42 degrees for exposure times of 30 minutes, 
1 hour and 3 hours. When these experiments were carried out, all the data for the 
hyperthermia experiments had not yet been obtained. Namely, the range of 44-49 
degrees had not yet been tested and hence, even though in retrospect it is known that 
different exposure times have no effect, as determined in Section 3.2.2, they were still 
investigated here. It was thought that even though hyperthermia at the low levels of 
41 and 42 degrees does not show any significant cell killing effect as shown in section 
3.2, that a combined regime could still show an overall supra-additive effect. It was 
hoped that the radiation exposure would allow the hyperthermia to inhibit critical cell 
repair mechanisms resulting in greater cell death even though hyperthermia by itself 
at these levels does not kill the cell. Graphs were generated for each set of parameters 
in which the normalised relative cell count, or relative response to the control groups, 
is shown.  
 Figure 3.9 considers the effect of combining various levels of radiation for the 






Figure 3.9: Combinations of various levels of radiation with hyperthermia at both 41 
and 42 degrees for exposure times of 30 minutes, 1 and 3 hours.  
 
At first glance, no real obvious differences exist between these graphs and it is 
difficult to analyse if there is a beneficial effect from combining these levels of 
radiation with the hyperthermia regimes. For these reasons, the level of cell kill from 
the hyperthermia alone and the radiation alone were plotted on the same plots, 
resulting in 13 curves on the same graph. As it is difficult to present this data clearly, 
these graphs were split up to show only seven curves on each plot. They have also 
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3 hour exposure at 42 degrees
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applied, denoted as figures 3.10, 3.11 and 3.12. Please note that the legends 
correspond to each row of plots they are beside, ‘H’ stands for hyperthermia. 
 







30 min. exposure at 41 degrees







30 min. exposure at 42 degrees






30 min. exposure at 41 degrees






30 min. exposure at 42 degrees
 
 
Figure 3.10: 30-minute exposures to hyperthermia at 41 and 42 degrees combined 
with various levels of radiation. Each legend corresponds to each row of plots. 
 
 The above plots indicate that there is an overall effect from combining levels 
of radiation with 30-minute exposures to hyperthermia at both 41 and 42 degrees. In 
almost all cases, there is some form of additive effect as the solid lines all fall well 
below the dashed ones. More interestingly, this effect does not seem to be observed as 
strongly when hyperthermia is applied for 1 hour as can be seen in figure 3.11. The  
1-hour exposures seems to indicate that there might be some small enhancement of 
cell kill from combining radiation with hyperthermia levels as for the lower radiation 
levels. However, the higher radiation levels (9, 11 and 15 Gy) do not display a clear 
distinction between radiation alone and the combined regimes. This may indicate that 
some form of saturation effect exists, in which the radiation at these higher levels 
dominates the level of cell kill that can be achieved. The level of hyperthermia 
















should be noted that this is of course is only speculation as testing this hypothesis was 
not in the scope of this project. 
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1 hour exposure at 42 degrees
 
 
Figure 3.11: 1-hour exposures to hyperthermia at 41 and 42 degrees combined with 
various levels of hyperthermia. Each legend corresponds to each row of plots.  
 
Similarly, in figure 3.12, the 3 hour exposures to both hyperthermia and radiation 
levels seems to indicate that indeed the lower levels of radiation benefit from a 
combined regime whereas the higher levels do not. Solely from this set of data, we 
cannot determine any of these factors with a high degree of certainty since the number 
of variables exceed the number of datasets significantly. Hence, it was not possible to 
run a statistical analysis of this data to either confirm or deny any possible trends that 
might appear to present themselves on the graphs. Section 3.5 presents multiple 
datasets for the same parameters thus enabling statistics to answer important questions 
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3 hour exposure at 42 degrees
 
 
Figure 3.12: 3-hour exposures to hyperthermia at 41 and 42 degrees combined with 
various levels of radiation. Each legend corresponds to each row of plots. 
 
 
3.5 COMBINED EXPERIMENTS – MULTIPLE DATASETS 
 
 Since the results from the first initial combined experiments can be regarded 
as inconclusive as to whether combining hyperthermia with radiation is beneficial, it 
was decided to acquire several other datasets. Due to logistical reasons imposing time 
constraints on the acquisition of these new sets, selective decisions were made as to 
which combinations of hyperthermia and radiation should be tested. Since radiation 
kills cells in a predictable manner, only two levels of radiation were selected 
alongside with three new levels of hyperthermia. Out of the radiation levels used 
previously, 5 and 11 Gy were chosen for these final experiments. This was done in 
order to observe the effects of a lower level of radiation that still showed cell kill, as 
seen in figure 3.7, along with a high level of radiation that seemed relatively 
unaffected by the addition of heat as observed in the initial combined experiments. 
The temperatures chosen for the addition of the hyperthermia regimes to radiation 
















was chosen since the previous data from 30 minutes was very noisy along with the 
data from 1 hour, whereas there is no difference in the effects from 2 and 3 hours as 
indicated in the statistics done for hyperthermia alone.  
 
3.5.1 COMBINING 5 GY WITH HYPERTHERMIA REGIMES 
 
 In this section, only the data from the combined experiments containing 5 Gy 
of radiation will be considered. For each individual temperature, 43, 45 and 47 
degrees, combined with 5 Gy of radiation, 6 datasets were acquired. All datasets were 
averaged in order to reduce the overall noise in each individual dataset (figure 3.13).  
 






































































Figure 3.13: Cell response to 5 Gy of radiation combined with 2 hour exposures to 
three levels of hyperthermia. All the data presented are the averages of six datasets. 
 
Figures 3.14 to 3.16 show the cell killing effects from hyperthermia alone, 
radiation alone and the combined regimes. Furthermore, one can add a curve that 
represents the theoretical levels of cell kill expected from the combined regimes, 
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based on the direct multiplication of the level of cell kill from hyperthermia alone 
with that from radiation alone. The data points and uncertainty bars for the 
experimental combined level of cell kill are included. This thus allows direct 
conclusions to be drawn as to whether there is a supra-additive effect from combining 
radiation with hyperthermia, simply an additive effect or whether one regime reduces 




Figure 3.14: Combining 43 degrees for 2 hours with 5 Gy of radiation. Comparison 
of the experimental and theoretical curves. 
 
 Figures 3.14 to 3.16 all indicate that 43, 45 and 47 degrees, when applied for 2 
hours, dominate over 5 Gy alone. The experimental combination of 43 degrees with 5 
Gy of radiation agrees, within uncertainty, with the theoretical combined curve for 
almost all data points. This would be expected for a directly additive effect from 
combining radiation with hyperthermia. For both 45 and 47 degrees, it can be seen 
that the experimental and theoretical curves agree within experimental uncertainty in 
most instances apart from the data points around 30 hours. It should be said, however, 
that this agreement is often only marginal and can only be interpreted as suggestive 
evidence that a direct additive effect is seen. 
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Figure 3.15: Combining 45 degrees for 2 hours with 5 Gy of radiation. Comparison 
of the experimental and theoretical curves 
 
 
 Figure 3.16: Combining 47 degrees for 2 hours with 5 Gy of radiation. Comparison 
of the experimental and theoretical curves. 
Hyperthermia at 47 degrees
5 Gy only
47 degrees + 5Gy
theoretical combined curve
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theoretical combined curve
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To test this statistically, an analysis of variance on all of these datasets was 
conducted. The null hypothesis tests that all sample means of all datasets is the same. 
From this it was found, that the cell killing effects of hyperthermia alone when 
compared with those of radiation alone are statistically significantly different with a 
p-value less than 0.001. This means that the cell kill induced by radiation is not 
dependent on that induced by hyperthermia. Since the difference between both the 
theoretical curves and the actual experimental data is very small it can therefore be 
said that hyperthermia when added to radiation presents a straightforward additive 
effect rather than a supra additive or a diminished effect.  
Figure 3.17 combines all of the data above on a single plot along with the cell 
killing effect from both hyperthermia and radiation alone. The ‘theoretical’ cell kill of 
each has been omitted from this graph for reasons of clarity. 
 




































Figure 3.17: Comparing the various levels of hyperthermia applied with the overall 
combined cell killing effects of 5 Gy plus 43, 45 and 47 degrees. 
 
 
Figure 3.17 allows for a direct comparison between the levels of hyperthermia 
applied, or in other words shows whether the different temperatures achieve different 
levels of cell kill. This graph is consistent with the convention that higher levels of 
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hyperthermia produce higher levels of cell kill than the lower levels. Combining 
radiation with hyperthermia does not change this convention as can be expected. 
 
3.5.2 COMBINING 11 GY WITH HYPERTHERMIA REGIMES 
 
 The same procedure was followed to analyse the results from all three 
hyperthermia levels combined with 11 Gy of radiation. It was initially hoped to again 
acquire 6 datasets for each individual temperature combined with 5 Gy, but 
unfortunately, due to unforeseeable circumstances, both one dataset and the 10 hour 
data points in all sets, had to be discarded, resulting in only 5 datasets analysed with 6 
data points on each. The averages of these datasets are shown in figure 3.18. 
 







































































Figure 3.18: Cell response to 5 Gy of radiation combined with 2 hour exposures to 
three levels of hyperthermia. All the data presented are the averages of five datasets. 
 
Redrawing these graphs to include the cell killing effects of radiation and 
hyperthermia alone, along with the theoretical estimate of direct addition of these two 




Figure 3.19: Combining 43 degrees for 2 hours with 11 Gy of radiation and 
comparing  the experimental and theoretical curves. 
 
 It is interesting to see that the cell killing effect from hyperthermia at 43 
degrees does not dominate over the cell killing effect of 11 Gy of radiation. At the 
higher levels of 45 and 47 degrees, however, as seen in figures 3.20 and 3.21, this is 
not the case, as hyperthermia strongly dominates the level of cell kill over 11 Gy of 
radiation. Furthermore, figure 3.19 shows that there might be an additive effect for 
combining hyperthermia with radiation as both the experimental and theoretical 
curves are reasonably close together even though both curves do not fall within the 
uncertainty bars most of the time. Figures 3.20 and 3.21, however, clearly do not 
present this phenomenon, as the curves do not agree at all. In fact, these curves tend to 
show that the higher levels of hyperthermia are in agreement with the experimental 
combined curves. Thus, suggesting that there is no added effect from combining 
hyperthermia with radiation. Another analysis of variance conducted on all of these 
datasets found that the combination of these levels of hyperthermia with radiation at 
11 Gy is still statistically significant with a p-value less than 0.001.  
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Figure 3.20: Combining 45 degrees for 2 hours with 11 Gy of radiation and 




Figure 3.21: Combining 47 degrees for 2 hours with 11 Gy of radiation and 
comparing  the experimental and theoretical curves. 
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This means that the means of the cell killing effects from hyperthermia alone when 
compared to those of radiation alone are statistically different. This confirms what 
was found for these levels of hyperthermia combined with 5 Gy as explained in 
Section 3.5.1. A statistically significant difference is to be expected since the 
experimental combined curve falls clearly below the hyperthermia alone and radiation 
alone curves. However, as noted earlier there is no agreement between the 
experimental and theoretical curves for 11 Gy and hence no direct additive effect is 
seen. It is unsure why this effect is seen for 5 Gy but not for 11 Gy. It could be 
possible that higher levels of radiation, when combined with high hyperthermia levels 
results in some form of saturation effect, in which the cell kill from the most dominant 
treatment takes over, in this case the hyperthermia treatment. 
When all this data is combined, as seen in figure 3.22, with the theoretical 
curves eliminated, then the combined levels of hyperthermia and radiation follow a 
chronological convention in which higher levels of hyperthermia result in higher 
levels of cell kill, as expected.  
 




































Figure 3.22: Comparing the cell killing effects of 43, 45 and 47 degrees, and 11 Gy of 




3.5.3 EXPLORING THE DIFFERENCES BETWEEN 5 AND 11 GY 
  
 Finally, after the combined regimes for 5 and 11 Gy were analysed separately, 
it is now possible to compare the radiation levels to one another to see if there is also 
a consistent chronological effect for radiation when combined with hyperthermia. 
This comparison results in three different graphs, figures 3.23 to 3.25, for each 
hyperthermia level and includes the levels of radiation by itself and their combined 
effects. Note that the data points and uncertainty bars have been added for the 
combined curves in order to determine whether there is a real difference between 
them. Recall, that the 11 Gy datasets are all missing the data point at 10 hours as seen 
for the 5 Gy datasets. 
 
 
Figure 3.23: The difference between 5 and 11 Gy when combined with 43 degrees 
 
After careful reanalysis of the data, it was found that the trends observed are indeed 
correct, however odd. From figures 3.23 to 3.25 the level of cell kill increases with 
temperature alone, with radiation alone, with respect to hyperthermia when combined 
with radiation but not with respect to radiation when combined with hyperthermia. 
The latter is somewhat unexpected.  
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Figure 3.25: The difference between 5 and 11 Gy when combined with 47 degrees 
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Furthermore, 5 Gy when combined with hyperthermia levels either agrees with, 
within uncertainties, or exceeds the combined levels found for 11 Gy as seen in the 
case of 45 degrees. Again, this can be a very good indication that some form of 
saturation effect exists, causing smaller amounts of radiation at certain temperatures 
to have more cell killing effect than higher levels of radiation. It is interesting to recall 
that the initial combined experiments showed the opposite effect, as radiation 
dominated instead of hyperthermia and no combined effect was seen. Reasons for not 
observing an overall combined effect, such as the possibility of saturation effects, are 
only speculation and could not be tested within the scope of this project.  
In summary, an additive effect from combining radiation with hyperthermia 
was found for 5 Gy combined with hyperthermia at 43, 45 and 47 degrees for 2 hours. 
This effect was marginal in the combinations of 45 and 47 degrees. 11 Gy when 
combined with the same hyperthermia regimes was not found to present an additive 
effect at all for any of the temperatures applied. Hence, a supra-additive effect was 
never observed and it was found that a direct additive effect of cell kill does not exist 













4.1  DISCUSSION 
 
 The initial aim of this research was to carry out basic in vitro experiments on 
the P388 mouse leukaemia cell line, in order to gain a fundamental understanding as 
to whether a supra-additive effect occurs when combining radiation with 
hyperthermia in the treatment of leukaemia. A framework was established, with MAF 
approval, at the University of Canterbury to allow these experiments to be carried out. 
The facilities and equipment available imposed various limitations on the set-ups of 
the experiments. In summary, the most important limitations of this project were the 
underestimation of cell kill from the Coulter counter and having to travel to and from 
Christchurch Hospital to use a linear accelerator to administer the radiation doses. 
Delays in obtaining the MAF approval and various pieces of equipment laid 
restrictions on the time available for this project and eventually resulted in fewer 
experimental datasets obtained than originally was hoped.  
 Throughout this project, 13 control group datasets were obtained and 
investigated. Normally, a logistic curve is used to represent population growth data 
that is restricted by its food supply, in our case the cells are restricted by the amount 
of media present. It was found that the ratio of number of cells seeded to media 
available was large, and that because of this, the initial exponential part of the logistic 
curve was not observed. The data was consequently fitted to a second order 
polynomial and this fit was found to approximate the data accurately and fall within 
the uncertainties. Following this, the control groups that travelled to and from 
 50 
Christchurch Hospital were compared with those that remained at the University of 
Canterbury. A visual difference between these two types of control groups was seen 
but a p-value of 0.07, however close to 0.05, indicated that these groups were not 
statistically significantly different. It was important to determine whether to correct all 
other datasets to their respective control groups on a weekly basis or to correct all 
datasets by one single averaged control group. It was decided, after careful 
consideration, to correct the rest of the data presented throughout this thesis on a 
weekly basis, in order to account for uncontrollable variations in factors such as the 
change in humidity of the room.  
 Hyperthermia experiments were conducted for a temperature range of 38-50 
degrees for durations of 30 minutes, 1 hour, 2 hours and 3 hours and used to 
determine the cell killing effects from hyperthermia alone. This data was plotted on an 
Arrhenius plot, which followed a straight line, indicating that no systematic error was 
present throughout the data. The statistical analysis of the hyperthermia data revealed 
that there was no dependence on exposure time.  
The hyperthermia experiments also indicated that strong temperature 
dependences exist for cell kill by hyperthermia, with a p-value less than 0.05. This 
general trend, however, did not exist for each temperature when compared with the 
control groups as seen in an unpaired t-test. The lower temperature range of 38-42 
degrees was found to have no effect whereas the range of 43-50 degrees displayed 
very high statistical significance with p-values less than 0.0001. This study also 
confirmed the findings by Harisladis et al. who showed that there is no cell kill for 
temperatures below 43 degrees and that for 43 degrees the exposure time must be 
longer than 30 minutes in order to achieve a detectable amount of cell kill 62. 
The cell kill from 1, 3, 5, 9, 11 and 15 Gy were investigated and demonstrated 
the familiar pattern that an increase in the radiation dose corresponds to an increase in 
levels of cell kill 20,31. The statistics indicated that there is indeed a statistically 
significant difference from applying radiation, as would be expected.  
When initially combining hyperthermia with radiation, not all results from 
hyperthermia alone had been obtained and hence the conclusion that exposure times 
had no effect, as previously discussed had not yet been drawn. At this time, it was 
proposed to investigate 41 and 42 degrees Celsius for 30 minutes, 1 hour and 3 hour 
exposure times combined with 1, 3, 5, 9, 11 and 15 Gy of radiation. Consequently, 
there were too many variables and not enough datasets to be able to draw concrete 
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conclusions, about the combination of hyperthermia and radiation. Visually, through 
graphs no strong additive effects were seen. 
The final combined experiments conducted, consisted of 5 and 11 Gy as 
radiation levels, each combined with 43, 45 and 47 degrees applied for 2 hours. The 
theoretical level of cell kill was estimated based on a direct additive effect from the 
cell kill from hyperthermia and radiation alone. The main assumption for a direct 
additive effect is that the cell kill from one variable is not dependent on the other. In 
the case of 5 Gy combined with these various levels of hyperthermia, a direct additive 
effect was observed as the theoretical and experimental curves agreed to a reasonable 
level of certainty. This however, was not seen for 11 Gy when combined with the 
various hyperthermia regimes in which the overall experimental cell kill did not agree 
with the predicted theoretical level of cell kill required for an additive effect. Instead, 
at 11 Gy the overall effect seemed diminished. When the two levels of radiation were 
compared, it was also found that 5 Gy when in combination with these levels of 
hyperthermia, induces higher levels of cell kill than 11 Gy for the same combinations. 
Reasons for this inconsistency cannot be provided since the mechanisms involved that 
produce the cell kill for both radiation and hyperthermia alone are known to be highly 
complex. In addition, the investigation of the combined effects of hyperthermia and 
radiation, at the microscopic level, which could possibly provide such reasons, was 
outside the scope of this thesis. It is suggested however, that some form of saturation 
effect could be present causing these results, but this is sheer speculation. An analysis 
of variance found that the combined regimes are statistically significantly dependent 
on both radiation and hyperthermia levels, as p-values of less than 0.05 were found. 
Overall, these results do not indicate that when combining hyperthermia with 
radiation, a straightforward additive effect will be consistently observed. Hence, the 
hypothesis of combining radiation with hyperthermia in the treatment of leukaemia is 
not supported by the results found in this thesis, as a consistent additive effect would 
be necessary. These experiments have thus found what is known as a null-result that 
does not support any further on going work for this particular cell line. It is difficult to 
compare these results with findings in the literature, as the differences in the 
methodologies used are often substantial. Most cell lines investigated, for example, 
can be plated in order to run clonogenic assays and the cell lines used are often solid 
tumours rather than lymphoid neoplasms or leukaemias. The studies conducted on 
local hyperthermia combined with radiation were discussed in Chapter 1: Research 
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motivation and background, and will not be reiterated here as deemed irrelevant. It is 
interesting, however, to discuss the findings and trials by Robbins et al. who have 
thus far had successful results from combining radiation with hyperthermia in the 
treatment of chronic leukaemias and lymphomas 63,64.  
In the studies by Robbins et al. the AKR murine leukaemia cell line has been 
investigated both in vitro and in vivo. These studies have maintained a focus on 
comparing the cell kill effects from hyperthermia on healthy haemopoietic cells with 
those on the AKR cell line 65. They found that hyperthermia at 41.8 degrees, or higher 
temperatures, selectively kills leukaemia cells both in vitro and in vivo whereas in this 
study no effect from 42 degrees was found. No cell experiments were carried out 
however, to test the combined effect from radiation and hyperthermia in vitro and 
hence our findings cannot be directly compared. The AKR mouse model was used, 
however, to test the combination of hyperthermia with TBI and found an increase in 
the survival of the mice 66. Shen et al. investigated the effects on the erythroleukaemia 
mouse for the combination of whole body hyperthermia with cyclophosphamide, a 
chemotherapeutic agent. The Cyclophosphamide combined with whole-body 
hyperthermia at 41.8 degrees also showed a prolonged survival of the mice 
undergoing this treatment 67. Robbins et al. continued to write a paper on the 
interaction of whole-body hyperthermia and irradiation in the treatment of AKR 
mouse leukaemia. They found a supra-additive killing effect from the hyperthermia 35. 
This is obviously different to what was found in this thesis, where no supra-additive 
effect has been observed. This difference cannot, however, be compared since in vitro 
cell lines react very differently to in vivo mechanisms.  
Ever since, a number of case studies have been performed on patients with 
Burkitt’s lymphoma and uncurable B-cell neoplastic diseases 64,68. One case study 
conducted by Wessalowski et al. combined whole-body hyperthermia with various 
chemotherapeutic agents in order to try and save a child with myelomonocytic 
leukaemia 69. Proposals and calls for phase II randomised trials to combine whole-
body hyperthermia with either radiation or chemotherapy or both have been made 
63,70
. On a final note, the clinical studies performed aim at increasing the overall cell 
kill of the leukaemias or lymphomas present in order to reduce the risk of relapse. 
They do not seem to aim at reducing the overall radiation or chemotherapy doses, 
which was why the investigations in this thesis were originally performed. 
 
 53 
4.2  FUTURE WORK 
 
  Even though in this thesis, a null-result was obtained, and hence, no further 
work is to be done using the P388 mouse leukaemia cell line, investigations into 
human leukaemia cell lines should be performed. This is because mouse cell lines are 
only an approximation of human cell lines and it is possible that in the case of 
combining hyperthermia with radiation, the human cell lines will respond differently. 
Similarly, to the investigations made by Robbins et al., one should investigate the 
different response from the human leukaemia cell line to its healthy counterparts. In 
addition, one must keep in mind that in the case of leukaemia one is discussing the 
possibilities of combining whole-body hyperthermia with radiation. Hence, the effects 
of whole-body hyperthermia when combined with radiation ought to be tested in an 
in-vivo mouse model to obtain any real indication as to whether combining 
hyperthermia with radiation is beneficial for the treatment of leukaemia. Robbins et 
al. only showed that heat selectively kills the cells but no papers were found showing 
exactly how much additional cell kill is obtained from adding hyperthermia to 
radiation. Hence, in their studies it was not determined if the possibility for lowering 
the radiation dose whilst maintaining the therapeutic index exists. 
 
4.3  CONCLUSION 
 
 In this thesis, basic in vitro experiments were carried out on the P388 mouse 
leukaemia cell line. It was investigated whether combining radiation with 
hyperthermia, in the case of leukaemia, results in an overall supra-additive cell killing 
effect or in an additive effect. The cell killing effects from both hyperthermia and 
radiation alone were initially determined. It was found that the exposure time to 
hyperthermia has no significant effect, but varying temperature, as was expected, does 
have statistically significant effects. Radiation levels were found to show the familiar 
pattern in which an increase in the level of radiation increases the amount of cell kill. 
Some initial combined experiments were performed but too many parameters were 
present in the data, resulting in no concrete conclusions. Because of this, multiple 
datasets were acquired for only two radiation levels, 5 and 11 Gy, and three 
hyperthermia temperatures, 43, 45 and 47 degrees Celsius. The analysis of these 
datasets revealed that no supra-additive effect is observed from combining radiation 
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with hyperthermia. In the case of 5 Gy, a consistent additive effect was found but for 
11 Gy a diminished effect in overall cell kill was seen. When comparing the 
combined effects based on the different radiation levels, it was found that 5 Gy, when 
combined with hyperthermia, results in the same or a higher level of cell kill than the 
cell killing effect from 11 Gy combined with hyperthermia. This is rather counter 
intuitive and inconsistent with the expectations that a higher level of radiation when 
combined with hyperthermia regimes will result in a higher level of cell kill. Reasons 
for this inconsistency cannot be given as the mechanisms that induce the cell kill from 
a combined regime should be investigated on the microscopic level, and such an 
investigation was outside the scope of this thesis.  
The overall conclusion drawn from this work is that there is no real beneficial 
effect for combining radiation with hyperthermia for the P388 mouse leukaemia cell 
line. No further investigations into the combination of hyperthermia and radiation for 
this cell line are needed. Human leukaemia cell lines and in vivo mouse models, 
however, should in the future be investigated. Human cell lines would benefit from a 
similar investigation, as it is possible that they will react differently to the combined 
regimes than the P388 mouse leukaemia cell line has. In vivo mouse models will take 
blood circulation effects throughout the body into account, which is the only way to 
determine whether there are any beneficial effects from combining radiation with 
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DETAILS OF THE PROJECT: 
 
It has been proposed to observe the 
cell-killing effect of P388 mouse 
leukaemia cells after hyperthermia, 
ionising radiation and after a 
combination of both these modalities 
has been applied. The details of the 
cell-line are as follows: P388 D1 
(Murine Leukaemia cells) ATCC CCL 
46 imported from ATCC on 28/03/02 
under MAF permit: 2002014613.  
The prime reason for observing this 
effect is to observe whether the 
hyperthermia will make the cells more 
sensitive to radiation, if so then 
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hyperthermia might have important 
beneficial consequences for future 
patients undergoing total body 
irradiation followed by a bone-marrow 
transplant. 
 
TEST-RUN AND HYPERTHERMIA 
EXPERIMENTS 
 
This work will be conducted by the 
technician Gill Ellis in her biohazard 
room (room 745 in Chemistry) when it 
is PC 2 approved. This work includes 
the following: 
The growing of these cells in culture 
and establishing what concentration of 
cells will work best for our 
experiments by doing a test-run. That 
is the filling of a 96-well-plate with 
different concentrations of cells and 
observing their natural cell-kill for a 
period of days. This cell-kill is read out 
by a spectrometer in this laboratory. 
 
The hyperthermia experiments are to 
be conducted by placing the same well 
plates into an incubator in this room 
and increasing the temperature in the 
incubator; from this, the cell-killing 
effect from different levels of 
hyperthermia alone can be established. 
 
IONISING RADIATION EXPERIMENTS 
 
The ionising radiation experiments are 
to be conducted in Treatment room 3, 
Lower Ground Level, Oncology 
Service, Christchurch Hospital, during 
after hours. The experiments will 
establish the cell-killing effect of 
different levels of ionising radiation on 
the leukaemia cells, and will determine 
which levels of radiation are best to be 
used in the combined experiments. The 
supervisor for the application of the 
radiation is the medical physicist Dr. 
Mark Bird. 
To do this, the cells will be dispensed 
into their wells in the biohazard room 
(room 745) in Chemistry by Gill Ellis. 
The cells have been classified as 
Infectious substances Category A, 
affecting animals only. Hence, the 
transport regulations UN 2900, set by 
the International Air Transport 
Association (IATA) apply. An outline 
for the design of the packaging 
including the primary receptacle, the 
secondary watertight container and the 
outer packaging can be found at the 
very end of this proposal. It should be 
noted that with these regulations in 
place, any spillage that might occur 
will be safely contained within the 
packaging. 
 
The package will be transported to  
Christchurch Hospital by car and there 
it will be placed under the Linear 
Accelerator, which will irradiate the 
whole package including the outer 
packaging. The x-rays will pass 
through the package and irradiate the 
cells inside. The entire package is then 
to be taken back to Chemistry 
immediately and placed back inside the 
biohazard room where the cells can be 
analysed. The whole procedure will 
take less than a few hours. The 
experiment is to be repeated a number 
of times with different radiation doses. 
Please Note: There is no need to take 
the cells out of the biohazard safe 
packaging during the experiment. The 
only place they are removed is in 
Chemistry laboratory, in the safe hands 
of Gill Ellis. 
There will be a maximum of 50 wells 
(on a 96 well plate) filled with a 
concentration of cells in culture. The 
concentration can only be established 
during the initial test-run but it is 
estimated to be around 8.4 x 104 
cells/ml dispensed into 400 µl wells of 
which about 150 µl will be used. 
 
 
COMBINING IONISING RADIATION 
AND HYPERTHERMIA 
 
This part of the experiment will follow 
the exact same protocols as outlined in 
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the separate hyperthermia and ionising 
sections above. It is proposed to apply 
hyperthermia to the cells before they 
travel their biohazard safe packaging to 
the hospital in the same fashion. 
 
All the above experiments that are to 
be conducted at Christchurch Hospital 
will in total comprise 1 trip per week 
over a total of approximately 10 
weeks. In each trip up to 4 containers 
will be transferred to the hospital and 
back. 
 
SPILLAGE AND CONTAINMENT 
 
At all times the cells will either be 
contained in the Biohazard Room 
(745) in Chemistry or be contained in 
the biohazard safe packaging. 
 
If at any time spillage does occur 
within the packaging, it will not be 
noted until the secondary packaging is 
examined in the biohazard room at 
which point the entire secondary 
packaging has become biohazard waste 
and will be disposed off according to 
MAF PC 2 regulations, which apply 




The only waste products from this 
experiment are the dead cells either 
due to us killing them or due to their 
own natural death. These waste 
products will be disposed of within the 
biohazard room according to MAF 





If you have any queries please do not 
hesitate to contact me, my supervisors 
or the qualified technicians (in their 
respective areas) who are helping me 
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Private Bag 4800, 
Christchurch, 
New Zealand 




Assoc. Prof Lou Reinisch 
lou.reinisch@canterbury.ac.nz 
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Christchurch, 
New Zealand 
Room 604, ext: 6493 
 
Dr. Juergen Meyer 
juergen.meyer@canterbury.ac.nz 
Department of Physics and Astronomy 
University of Canterbury, 
Private Bag 4800, 
Christchurch, 
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Room 820, ext: 7588 
 





Department of Chemistry 
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DESIGN OF THE BIOHAZARD CONTAINER 
 
The following outlines the design of the biohazard packaging as required according 
to IATA packing instructions 602 and the Guidance Document for infectious 
substances. Please note that the packing instructions follow infectious substances 
category A, affecting animals only (UN 2900) 
 
THE PRIMARY RECEPTACLE: 
 
We initially have a plate with 96 wells of which approximately 20 to 50 wells are 
filled at a time with cells dispersed in their media. Since the well is open at the top, it 




The rubber seal shown contains all the liquid within each well. This has been tested 
by using some blue and red food colouring. Next, we place the original lid of the plate 
on top and then wrap it all tightly up with glad-wrap. This serves as our primary 
receptacle. 
 
THE SECONDARY PACKAGING 
 
The secondary packaging is both water- and air-tight, and can withstand temperatures 
of at least 100 degrees Celsius and it is estimated that it will at least withstand 
temperatures below -15 degrees Celsius.  
 
The packaging has been tested to indeed be watertight (it was filled full with water 
and shaken vigorously upside down and left upside down for over an hour and 
nothing leaked through).  
 
The primary receptacle is placed inside the secondary packaging and is surrounded 
with cotton wool. The cotton wool holds the primary receptacle in place, and will 
absorb any leakage from the primary receptacle if it were to occur.  
 
The secondary packaging locks on all four sides of the container and is made of thick 





A specimen record is to be attached to the secondary packaging that includes an 
itemized list of contents. In this case, it will read along the following lines: 
 
P388 mouse lymphoid leukaemia cells dispersed in media of concentration such and 
such with X amount of wells filled at a total quantity of X ml. 
 
THE OUTER PACKAGING: 
 
The outer packaging must be rigid and of adequate strength for its weight, capacity 
and intended use as in accordance with Packing instruction 602 from the IATA. We 
have bought a container of the same description as the secondary packaging but 
slightly bigger so that the secondary fits inside. To stop the secondary from moving 
the container is filled up with more cotton wool and this has been tested to show that 
it holds it securely in place. 
 
The outer packaging will be labelled in accordance with packing instructions 602 and 
the IATA Guidance Document for infectious substances resulting in the following 
labels to be made and attached to the outer packaging.  
 
The picture on the following page  shows these labels and comes from Annex 3 in the 





Please Note: The supplier will be Gill Ellis from the Department of Chemistry at the 
University of Canterbury and the consignee will be Dr. Mark Bird at Christchurch 
Hospital. I, or one of my supervisors can/will be the person responsible for the 
package. Finally, the UN code used will be UN 2900 as the infectious substance only 
affects animals and thus the above label shown as an example will be changed 
slightly. Professor Bill Davison will be included as a contact person as the Operator of 
Transitional Facilities (rm 559) in the School of Biological Sciences. 
 
A ‘DO NOT OPEN’ label will also be affixed to the outer packaging. 
 
TRANSPORT TO THE HOSPITAL 
 
Finally, the entire package as described above will be placed in a small chilli-bin such 
that three or four of these packages can be transported at once to the hospital and 
back. This will allow us to complete the experiments faster and make fewer trips to 
the hospital. Please note that we would only ever have four such packages as 






P-values from unpaired t-tests for hyperthermia 




This first table provides all the p-values as determined from an unpaired t-test in 






0 Gy, 1 Gy .0859 
0 Gy, 3 Gy .3961 
0 Gy, 5 Gy .0340 
0 Gy, 9 Gy .0741 
0 Gy, 11 Gy .0360 
0 Gy, 15 Gy .0283 
1 Gy, 3 Gy .0187 
1 Gy, 5 Gy .0186 
1 Gy, 9 Gy .0273 
1 Gy, 11 Gy .0209 
1 Gy, 15 Gy .0185 
3 Gy, 5 Gy .0260 
3 Gy, 9 Gy .0598 
3 Gy, 11 Gy .0313 
3 Gy, 15 Gy .0254 
5 Gy, 9 Gy .3692 
5 Gy, 11 Gy .0453 
5 Gy, 15 Gy .0277 
9 Gy, 11 Gy .0245 
9 Gy, 15 Gy .0167 
11 Gy, 15 Gy .1098 
 
Table C.1: Statistical comparison of every radiation levels in an unpaired t-test. 
 
The following table provides all the p-values as found from an unpaired t-test 
conducted on all hyperthermia data comparing every temperature to one another. It 
should be noted that exposure times is not taken into account. P-values less than 0.05 
indicate that the difference between the two temperatures is statistically significant. 
As an example: 37,38 compares 37 degrees with 38 degrees and the p-value of .2764 









37, 38 .2764 
37, 39 .9722 
37, 40 .0643 
37, 41 .0681 
37, 42 .0803 
37, 43 <.0001 
37, 44 <.0001 
37, 45 <.0001 
37, 46 <.0001 
37, 47 <.0001 
37, 48 <.0001 
37, 49 <.0001 
37, 50 <.0001 
38, 39 .3453 
38, 40 .4597 
38, 41 .5234 
38, 42 .0018 
38, 43 <.0001 
38, 44 .0176 
38, 45 <.0001 
38, 46 <.0001 
38, 47 <.0001 
38, 48 <.0001 
38, 49 <.0001 
38, 50 <.0001 
39, 40 .0985 
39, 41 .1067 
39, 42 .1200 
39, 43 .0001 
39, 44 <.0001 
39, 45 .0026 
39, 46 <.0001 
39, 47 <.0001 
39, 48 <.0001 
39, 49 <.0001 
39, 50 <.0001 
40, 41 .9820 
40, 42 .9198 
40, 43 .0134 
40, 44 <.0001 
40, 45 .0635 
40, 46 <.0001 
40, 47 <.0001 
40, 48 <.0001 
40, 49 <.0001 
40, 50 <.0001 
41, 42 .9388 
41, 43 .0141 
41, 44 <.0001 
41, 45 .0634 
41, 46 <.0001 
41, 47 <.0001 
41, 48 <.0001 
41, 49 <.0001 
41, 50 <.0001 
 
 





42, 43 .0105 
42, 44 <.0001 
42, 45 .0544 
42, 46 <.0001 
42, 47 <.0001 
42, 48 <.0001 
42, 49 <.0001 
42, 50 <.0001 
43, 44 .0107 
43, 45 .9091 
43, 46 .0343 
43, 47 .0010 
43, 48 <.0001 
43, 49 <.0001 
43, 50 <.0001 
44, 45 .1446 
44, 46 .9671 
44, 47 .1774 
44, 48 .0009 
44, 49 <.0001 
44, 50 <.0001 
45, 46 .1828 
45, 47 .0308 
45, 48 .0027 
45, 49 .0009 
45, 50 .0005 
46, 47 .2338 
46, 48 .0114 
46, 49 .0019 
46, 50 .0008 
47, 48 .2983 
47, 49 .0975 
47, 50 .0589 
48, 49 .1954 
48, 50 .0570 
49, 50 .6254 
 
Table C.2 continued: Statistical comparison of all hyperthermia levels in an unpaired 
t-test. 
 
 
